Please visit https://www.fda.gov for more information about the rare condition called NAION (nonarteritic anterior ischemic optic neuropathy) risk with weight loss and antidiabetic GLP-1 medications.
Meet Dr. Cathy Rosenbaum
Meet Dr. Cathy Rosenbaum
Please visit https://www.fda.gov for more information about the rare condition called NAION (nonarteritic anterior ischemic optic neuropathy) risk with weight loss and antidiabetic GLP-1 medications.